Phlebology-focused thermal cure for severe chronic venous insufficiency at Saint-Eloy Thermal Center.
Official title: Therapeutic Efficacy of the Phlebology-oriented Thermal Cure at the Saint-Eloy Thermal Center in the Treatment of Symptoms of Severe Chronic Venous Insufficiency
Run by Société d'Exploitation des Thermes d'Amnéville · NCT07362719 · Data updated 2026-11-12
This will test whether a three-week phlebology-focused thermal cure at Saint-Eloy helps adults with severe chronic venous insufficiency of the legs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | Société d'Exploitation des Thermes d'Amnéville Academic / other |
| Locations | 1 site (Amnéville) |
| Status | Recruiting |
| Started | February 27, 2026 |
| Main results expected | February 2027 |
| Study ends | May 2027 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT07362719 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with severe lower-limb chronic venous insufficiency (CEAP C4a,b,c or C5) confirmed by Doppler who can undertake a three-week consecutive thermal cure at Saint-Eloy and attend six months of follow-up are ideal candidates.
✕Probably not a fit
People without severe CVI, those unable to commit to a three-week stay or follow-up visits, or those with contraindications to thermal therapies are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program offers a three-week consecutive phlebology-oriented thermal cure using the Amnéville-les-Thermes waters at the Saint-Eloy Thermal Center, followed by six months of clinical follow-up. Eligible adults have severe chronic venous insufficiency (CEAP C4a,b,c or C5) confirmed by venous Doppler and an indication for a phlebology-focused thermal cure. The protocol collects clinical safety and symptom outcomes over the immediate treatment period and during scheduled follow-up visits. The approach builds on balneotherapy practice as a lower-cost, noninvasive option alongside existing medical and surgical care.
Why it matters
Potential benefit: If successful, this treatment could reduce leg symptoms and skin complications from severe chronic venous insufficiency and offer a lower-cost noninvasive option.
How similar studies have gone: Previous balneotherapy research has shown modest symptomatic benefits for venous disease, but phlebology-oriented thermal cures have limited rigorous randomized trial data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult male or female (≥ 18 years of age). * Patients with severe chronic venous insufficiency of the lower limbs (C4a,b,c - C5 according to the CEAP (Clinical manifestations, Etiology, Anatomic distibution, Pathophysiology) classification (2020 revision) for at least one of the legs) confirmed by venous Doppler ultrasound of the lower limbs. * Patients with an indication for a thermal cure exclusively focused on phlebology. * Patients available to participate in a 3-week consecutive thermal cure at the Saint-Eloy Thermal Center, followed by 6 months of clinical follow-up, in accordance with the protocol schedule. * Patients available to attend the visits scheduled in the protocol and able to complete the data collection documents. * For women of childbearing age: patient using effective contraception. * Patient affiliated with a health insurance plan or beneficiary (Art. L.1121-8-1, French Public Health Code). * Patient who has given their informed consent in writing regarding their participation in the protocol. Exclusion Criteria: * Patients with a contraindication to thermal cure. * Patients who have participated in thermal cure (regardless of type) within the last 9 months. * Patients who have had an ulcer on their lower limbs that has healed within the last 3 months. * Patients without venous trophic disorders of the lower limbs, and in particular patients with isolated class C3 chronic venous insufficiency or less in both lower limbs. * Patients with an open ulcer on a lower limb (class C6). * Patients for whom interventional venous treatment is due to begin within the next 6 months. * Patients scheduled to undergo orthopedic surgery on the lower limbs within the next 6 months. * Patients who are unable to walk. * Patients with a known allergy to sulfur. * Patients with any medically significant findings or significant history that may impact safety, interpretation of results, and/or subject participation in the study at 6 months, in the investigator's opinion. * Patients simultaneously participating in another clinical trial or who have participated in another clinical trial for which the exclusion period has not ended. * Vulnerable persons (Art. L.1121-5 to 8, and L1122-1-2, French Public Health Code).
Where it's running
-
Centre Thermal Saint-Eloy
Amnéville, France Recruiting
Study contacts
- Principal investigator: Claudine INVERNIZZI
- Study coordinator: Ophélie FLAGEUL
- Email: o.flageul@slbpharma.com
- Phone: +33 2 99 12 19 62
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing radiofrequency and microwave treatments for small varicose veins
This study is testing whether ultrasound-guided radiofrequency or microwave treatments work better for people with small varicose veins.
-
New gel treatment for venous leg ulcers
This study is testing a new gel treatment for people with stubborn venous leg ulcers to see if it helps them heal better than just the usual care.
-
Tissue Repair Gel for treating Venous Leg Ulcers
This study is testing a new gel to see if it helps people with stubborn leg ulcers heal better when used with standard treatment compared to standard treatment alone.
-
Observing pain during microwave treatment for varicose veins
This study looks at how much pain patients feel during microwave treatment for varicose veins to see if different factors like age and weight affect their experience, with the goal of making the procedure more comfortable.
-
PAW-hydrogel to help chronic wounds like diabetic foot and leg ulcers heal faster
This trial will test whether a plasma-activated water–infused Carbopol® 940 hydrogel helps adults with long-standing wounds (diabetic foot, pressure, venous, arterial, or dehiscent ulcers) heal faster and have less bacteria compared with standard advanced wound care.
-
GORE VIABAHN FORTEGRA Venous Stent Post-Approval Study
This study tests the GORE VIABAHN FORTEGRA Venous Stent in real-world patients with venous diseases to see how it performs after it is approved.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.